Clinical Trials Browser

Phase 2 × Active not recruiting × glasdegib × Clear all

NCT04231851 2026-03-06

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Phase 2 Active not recruiting

30 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute